HPV Vaccine Only Partially Effective; The CBCD Reviews the Scientific Literature

Industry: Health & Fitness

“Women who were vaccinated nevertheless developed cervical cancer,” according to The Jerusalem Post (1). (September 22, 2013.) The CBCD reviews the article.

New York (PRUnderground) May 27th, 2014

The Center for the Biology of Chronic Disease (CBCD) recently became aware that Dr. Uzi Beller, an international authority on gynecological cancers, urged caution at a meeting in Tel Aviv with over “40 leading experts on gynecology, oncology, women’s health, vaccines and other specialties (1).” The meeting was held to discuss “the pros and cons of the HPV vaccine (1).”

“I want to see fundamental studies proving efficacy, and they do not exist (1).” The vaccines, Beller said, “were tested on mostly white women attending colleges and university – mostly from developed countries and healthy. The data were based on a relatively short term follow-up period. What is known does not yet justify widespread vaccination of healthy girls (1).”

In addition, Dr. Beller said that “there is no evidence that prophylactic (preventative) vaccination against HPV types 16 and 18 reduces the incidence of cervical cancer,” Beller declared. As the vaccine costs $100 to $360 for three doses in wealthy countries, it is completely out of the reach of developing countries, where an effective vaccine would be most urgently needed (1).”

The Jerusalem Post report concluded that “pediatricians are important advocates for preventive medicine, but they may know little about HPV infection and cervical and other HPV-related cancers. Obstetricians / Gynecologists know about HPV and cervical cancer prevention, but they often know little about vaccines and immunization delivery (1).”

“We believe doctors need facts. Many times, they’re recommending vaccination to their patients because that’s the shpiel they get from the CDC and the FDA. We believe many doctors would choose to recommend a more natural approach if they could be sure of that approach’s safety and efficacy. We’re happy to say that a study conducted by our Center showed exactly that.” – Greg Bennett, CBCD

A recent post marketing clinical study published in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs on August 12, 2013 showed that Gene-Eden-VIR reduced HPV symptoms and was safe and effective (2). “Up to 70% of those studied reported a decrease in viral symptoms (2).”

Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of HPV (2).

Interested individuals can view the two published studies on natural antiviral products here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

More information about these treatments can be found on the Center’s website at: http://www.cbcd.net/herpes-cures-that-work.php

The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases.

Reference:

(1) HPV: To vaccinate or not to vaccinate. Published on September 21, 2013.

http://www.jpost.com/Health-and-Science/HPV-To-vaccinate-or-not-to-vaccinate-326711

(2)    Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published September 2013.

http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php

About CBCD

About CBCD

The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Become a Fan

Press Contact

Name
Greg Bennett
Phone
585-250-9999
Email
info
0489d8c014117bbce2082901010d83f6
@cbcd.net
Website
http://www.cbcd.net

Image Gallery

Website